| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |